Latest news with #SuneetaReddy
Mint
5 hours ago
- Business
- Mint
Apollo Hospitals share price jumps over 4% 50 52-week high on plans to list digital health, pharmacy businesses
Apollo Hospitals share price rallied over 4% to hit 52-week high on Tuesday after the company's board approved separate listing of its omnichannel pharmacy and digital health businesses within 18-21 months, as part of reorganisation exercise to unlock value. Apollo Hospitals shares jumped as much as 4.7% to a fresh high of ₹ 7,583.30 apiece on the BSE. The board of directors of Apollo Hospitals Enterprise and Apollo HealthCo, a subsidiary of the healthcare major, have accorded in-principle approval for the composite scheme of arrangement. The scheme entails the demerger of the Omni Channel Pharma and Digital Health business - comprising the telehealth business of Apollo and its investment in Apollo HealthCo Ltd - into a new entity. Following the demerger, the scheme provides for the amalgamation of Apollo HealthCo with the new entity. This will subsequently be followed by the amalgamation of Keimed Pvt Ltd with NewCo (new entity). 'The proposed transaction will result in the creation of the largest, integrated omni-channel healthcare eco-system with a FY25 revenue of ₹ 16,300 crores ($1.9 billion) in FY25,' Apollo Hospitals said in a release. The business will comprise - Apollo 24/7, the digital health platform; the offline pharma distribution of AHL; Third party pharma distribution of Keimed; and telehealth services of AHEL. 'The combination of businesses is anticipated to generate substantial synergies, and the New Co is expected to achieve a revenue run rate of ₹ 25,000 crores ($2.9 billion) by FY27,' the company added. Upon the effectiveness of the Scheme, the new entity will become an Indian Owned and Controlled Company (IOCC) and will apply for listing on the stock exchanges, it added. The listing is expected within 18-21 months, the healthcare major said. For every 100 shares of Apollo Hospitals Enterprise, the shareholders of Apollo Hospitals Enterprise will receive 195.2 shares of NewCo, enabling their direct participation in the value unlock. Upon becoming an IOCC, the entity also proposes to consolidate the front-end pharmacy business by acquiring the remaining 74.5% stake in Apollo Medicals Pvt Ltd (AMPL), which owns 100% of Apollo Pharmacies Limited (APL), it said. Apollo Hospitals Enterprise will retain a 15% stake in the 'NewCo' to ensure an integrated, seamless, and comprehensive healthcare offering across the patient lifecycle, it added. Apollo Hospitals Enterprise MD Suneeta Reddy said the proposal enables the healthcare provider's shareholders to gain direct shareholding to country's largest omni-channel pharmacy and digital health platform. Apollo Hospitals share price has risen 9% in one month, and more than 12% in three months. The stock is up just 1% on a year-to-date (YTD) basis, but has rallied 22% in one year. Apollo Hospitals shares have delivered mutlibagger returns of 466% in the past five years. At 10:15 AM, Apollo Hospitals share price was trading 3.28% higher at ₹ 7,480.00 apiece on the BSE. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Time of India
17 hours ago
- Business
- Time of India
Apollo Hospitals to hive-off pharmacy, digital health businesses
Apollo Hospitals Enterprise on Monday said its board has approved separate listing of its omnichannel pharmacy and digital health businesses within 18-21 months, as part of reorganisation exercise to unlock value. The board of directors of Apollo Hospitals and Apollo HealthCo, a subsidiary of the the healthcare major, have accorded in-principle approval for the composite scheme of arrangement. The scheme entails the demerger of the Omni Channel Pharma and Digital Health business -- comprising the telehealth business of Apollo and its investment in AHL (Apollo HealthCo Limited) -- into a new entity. Following the demerger, the scheme provides for the amalgamation of AHL with the new entity. It would subsequently be followed by the amalgamation of Keimed Pvt Ltd , India's leading wholesale pharmaceutical distributor, with NewCo (new entity). Live Events The scheme creates a formidable omnichannel pharmacy distribution and digital health platform leader in India, with stated plans to achieve Rs 25,000 crore revenue by FY27, Apollo Hospitals Enterprise said in a regulatory filing. Upon the effectiveness of the Scheme, the new entity will become an Indian Owned and Controlled Company (IOCC) and will apply for listing on the stock exchanges, it added. The listing is expected within 18-21 months, the healthcare major said. Upon becoming an IOCC, the entity also proposes to consolidate the front-end pharmacy business by acquiring the remaining 74.5 per cent stake in Apollo Medicals Pvt Ltd (AMPL), which owns 100 per cent of Apollo Pharmacies Limited (APL), it said. Apollo Hospitals Enterprise Ltd (AHEL) will retain 15 per cent stake in the 'NewCo' to ensure an integrated, seamless, and comprehensive healthcare offering across the patient lifecycle, it added. "The omnichannel pharmacy business and integrated digital healthcare ecosystem will be a unique model to enable access to high-quality healthcare for millions of Indians," Apollo Hospitals Group Chairman Prathap C Reddy said. Apollo Hospitals Enterprise MD Suneeta Reddy said the proposal enables the healthcare provider's shareholders to gain direct shareholding to country's largest omni-channel pharmacy and digital health platform. "The new entity, once integrated, will be a truly customer-focused healthcare leader, with capabilities across the value chain. Delivering medicines seamlessly from 7000+ physical stores, online delivery platform serving over 19,000 pincodes, with Keimed ensuring supply chain integrity, our aspiration is that we will serve over 100 million Indians," Apollo HealthCo Executive Chairperson Shobana Kamineni said. Shares of Apollo Hospitals Enterprise ended 0.87 per cent down at Rs 7,242.75 apiece on BSE. Economic Times WhatsApp channel )
Time of India
18 hours ago
- Business
- Time of India
Apollo Hospitals approves major restructuring plans; to list digital health, pharmacy arms
Apollo Hospitals Enterprise Limited's ( AHEL ) board on Monday announced a sweeping corporate overhaul, approving a composite scheme of arrangement involving its subsidiaries Apollo Healthco Limited (AHL) and Keimed Private Limited, alongside its wholly owned subsidiary Apollo Healthtech Limited. Under the restructuring exercise, the company will first demerge its 'Identified Business Undertaking' into Apollo Healthtech. Subsequently, both AHL and Keimed Private Limited will be merged into Apollo Healthtech, consolidating critical operations under one roof. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like My baby is in so much pain, please help us? Donate For Health Donate Now Undo Through this move, AHEL aims to unlock value through strategic reorganisation, enabling direct listing of its Omni Channel Pharmacy and Digital Health business, a company filing to the exchanges said. "Composite Scheme creates a formidable Omni Channel Pharmacy Distribution and Digital Health platform leader in India, with scale of Rs 16,300 crores (US$1.9bn) of revenue in FY25, with stated plans to achieve Rs 25,000 crores revenue by FY27, with 7% EBITDA margin," the company filing added. Following this transaction, Apollo Healthtech Limited will seek listing of its equity shares on the NSE and BSE, paving the way for investors to participate directly in the reorganised entity. Live Events Additionally, Apollo disclosed an agreement signed on June 30, 2025, between Rasmeli Limited, an existing shareholder of AHL, and AHL promoter Shobana Kamineni. Rasmeli agreed to share a portion of its investment upside with the promoter and key employees, aligning interests and rewarding performance. AHEL shareholders to have direct shareholding in a combined entity. For every 100 shares of AHEL, AHEL shareholders will receive 195.2 shares of the new entity. Listing of the entity is expected in 18-21 months, the company filing said. Commenting on the development, Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise, said, "This comprehensive integrated network, overlaid with a strong digital layer, will allow us to create an impact of magnitude greater than could be achieved with a single format of care. This proposal enables AHEL shareholders to gain direct shareholding in India's largest Omni-Channel Pharmacy and Digital Health Platform, enabling full value discovery and eliminating any hold co discount in valuation. Meanwhile, AHEL will continue its focus on healthcare delivery, she added.
Economic Times
18 hours ago
- Business
- Economic Times
Apollo Hospitals approves major restructuring plans; to list digital health, pharmacy arms
Apollo Hospitals Enterprise Limited's (AHEL) board on Monday announced a sweeping corporate overhaul, approving a composite scheme of arrangement involving its subsidiaries Apollo Healthco Limited (AHL) and Keimed Private Limited, alongside its wholly owned subsidiary Apollo Healthtech Limited. ADVERTISEMENT Under the restructuring exercise, the company will first demerge its 'Identified Business Undertaking' into Apollo Healthtech. Subsequently, both AHL and Keimed Private Limited will be merged into Apollo Healthtech, consolidating critical operations under one roof. Through this move, AHEL aims to unlock value through strategic reorganisation, enabling direct listing of its Omni Channel Pharmacy and Digital Health business, a company filing to the exchanges said. "Composite Scheme creates a formidable Omni Channel Pharmacy Distribution and Digital Health platform leader in India, with scale of Rs 16,300 crores (US$1.9bn) of revenue in FY25, with stated plans to achieve Rs 25,000 crores revenue by FY27, with 7% EBITDA margin," the company filing this transaction, Apollo Healthtech Limited will seek listing of its equity shares on the NSE and BSE, paving the way for investors to participate directly in the reorganised Apollo disclosed an agreement signed on June 30, 2025, between Rasmeli Limited, an existing shareholder of AHL, and AHL promoter Shobana Kamineni. Rasmeli agreed to share a portion of its investment upside with the promoter and key employees, aligning interests and rewarding performance. ADVERTISEMENT AHEL shareholders to have direct shareholding in a combined entity. For every 100 shares of AHEL, AHEL shareholders will receive 195.2 shares of the new entity. Listing of the entity is expected in 18-21 months, the company filing on the development, Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise, said, "This comprehensive integrated network, overlaid with a strong digital layer, will allow us to create an impact of magnitude greater than could be achieved with a single format of care. This proposal enables AHEL shareholders to gain direct shareholding in India's largest Omni-Channel Pharmacy and Digital Health Platform, enabling full value discovery and eliminating any hold co discount in valuation. ADVERTISEMENT Meanwhile, AHEL will continue its focus on healthcare delivery, she added. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Bloomberg
11-04-2025
- Business
- Bloomberg
Apollo Hospitals Planning Buyouts to Boost North India Footprint
Apollo Hospitals Enterprise Ltd., India's largest health care provider by number of beds, is scouting for acquisitions to capitalize on a surge in demand for high-end medical care in the world's most-populous nation, its top executive said. The Chennai-based company is looking to grow across India's urban centers through acquisitions as well as starting projects from ground-up in northern India as well as in the state of Karnataka, and cities such as Kolkata, Hyderabad, and Mumbai, its Managing Director Suneeta Reddy said in an interview this week.
